Persistent sore throat, red eyes upon waking, rash on the arms: these signals do not resemble Covid as we knew it in 2020. The variants circulating in France since late 2025 have changed the face of the infection. The virus now affects the ENT sphere more and causes symptoms that many patients confuse with an allergy or a simple cold.
Understanding these atypical symptoms allows for quick action, timely testing, and protecting those around you. Here’s what French surveillance data reveals about the clinical profile of Covid infections in 2026.
Conjunctivitis and ocular signs related to Covid in 2026
Have you ever had irritated eyes during a cold without paying attention? In 2026, this sign deserves a second look. Syndromic surveillance reports (SOS Médecins network, Santé publique France) indicate a parallel increase in conjunctivitis and upper respiratory infections during recent waves.
Specifically, this manifests as red, watery eyes, sometimes stuck together in the morning. This is not a classic seasonal allergy: the symptom appears alongside a sore throat or nasal congestion. This “red eyes + ENT” association distinguishes the current profile from historical strains, which primarily had a pulmonary tropism.
For healthcare professionals, isolated conjunctivitis is not enough to diagnose Covid. However, when combined with sudden fatigue or muscle pain, it constitutes a warning signal that justifies a self-test. It is precisely this combination of signs that the new Covid variant 2026 in France details through the latest available clinical data.
Skin rashes and digestive symptoms: Covid beyond the respiratory tract
Covid is no longer limited to cough and fever. Two categories of symptoms surprise patients because they do not spontaneously suggest a respiratory viral infection.
Skin manifestations of the 2026 variant
Rashes resembling hives or lesions similar to frostbite on the toes and fingers have been documented during recent waves. These signs sometimes appear before fever, complicating the initial diagnosis. An unexplained rash associated with fatigue justifies a Covid test.
These manifestations affect both adults and children. They usually disappear within a few days, but their delayed appearance compared to respiratory symptoms often delays screening.
Digestive disorders as the first sign of infection
Nausea, vomiting, abdominal pain: these digestive symptoms are among the documented manifestations of current variants. Pharmavia notes that the 2025-2026 variants cause more digestive manifestations than the original strains.
The trap is simple: a patient who is vomiting thinks of gastroenteritis. They do not test, remain in contact with their loved ones, and unknowingly spread the virus. Isolated digestive disorders can be the only manifestation of the current Covid.
Neurological and sensory symptoms of recent variants
The loss of taste and smell, long considered the hallmark of Covid, has significantly declined with the Omicron variants and their descendants. In 2026, other sensory and neurological disorders are taking over.
- Early brain fog: difficulty concentrating, feeling of having a “cotton” head, unusual forgetfulness from the first days of infection. This symptom sometimes appears without fever or cough.
- Tinnitus and dizziness: patients report ringing in the ears or a sensation of imbalance during the acute phase. These disorders, documented in surveillance data, are often wrongly attributed to a trivial ENT problem.
- Disproportionate fatigue: a sudden exhaustion, without prior physical effort, that lasts several days. This is not the fatigue of an ordinary cold: patients describe an inability to maintain their daily activities.
- Headaches resistant to common pain relievers: intense headaches, localized behind the eyes or on the forehead, that do not respond to usual paracetamol.
These neurological signals pose a differential diagnosis problem. A patient presenting only dizziness and fatigue rarely consults for Covid. The reflex for a rapid test remains the best strategy to clarify the doubt.
Long Covid in 2026: an evolving profile of sequelae
Atypical symptoms of the acute phase sometimes persist well beyond the infection. The profile of long Covid observed in 2026 is more centered on sensory and cognitive disorders than on chronic respiratory impairments from the earlier waves.
Patients report persistent concentration difficulties for several weeks, sleep disturbances, and a residual chronic fatigue that significantly impacts daily life. These sequelae also affect individuals who had mild forms of the infection, making prevention even more relevant.
The fact that severe pulmonary forms have decreased may create a false sense of security. Long-term complications have not disappeared; they have simply changed their appearance.
Differentiating Covid from a cold or flu in 2026
The confusion between Covid, seasonal flu, and a classic cold is the main obstacle to rapid screening. A few markers help clarify the situation.
A cold causes abundant and clear nasal discharge, rarely fever. The flu sets in abruptly with high fever, intense body aches, and a dry cough. Covid 2026 is distinguished by the association of ENT signs with unusual symptoms (conjunctivitis, rash, digestive disorders, or brain fog).
The incubation period also plays a role: current variants have a very short incubation period, around two to three days, compared to four to five days for historical strains. Symptoms therefore appear quickly after contact with an infected person.
In case of any doubt, an antigen self-test remains the most accessible tool. A negative result on an initial test does not rule out infection: retesting after 48 hours increases the reliability of screening, especially in the presence of atypical symptoms.
The clinical profile of Covid has changed, and screening reflexes must follow. A sore throat accompanied by red eyes or a rash is no longer trivial. Testing early, even in the absence of cough or fever, remains the most effective response to limit transmission and timely identify an infection that no longer resembles that of 2020.